NEW YORK, Sept. 28 - Orchid BioSciences has won a three-year, $4.8 million contract from the Office of Special Technology of the US Defense Advanced Research Projects Agency to develop technology for microfluidic-enabled DNA synthesis that can produce “significant quantities” of long oligos, the company said on Friday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.